James Bylund, Chief Operating Officer at REPLIGEN CORP (RGEN), sold 2,000 shares at $240.40 ($481K) on 2022-08-03, disclosed to the SEC on 2022-08-04.
Open-market sale of $481k RGEN by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RGEN | SELL | 2021-04-08 | $74K | — | Filing → |